• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Complete Transurethral Resection of Large Non-Muscle-Invasive Bladder Cancer Preoperatively Suspected to Be Muscle-Invasive Disease : A Case Report and Literature Review].

作者信息

Fujimoto Takeru, Sakamoto Hiromasa, Nakashima Masakazu, Imai Kazuto, Akahane Mizuho, Sakurai Takaki, Aoyama Teruyoshi

机构信息

The Department of Urology, Kansai Electric Power Hospital.

The Department of Diagnostic Pathology, Kansai Electric Power Hospital.

出版信息

Hinyokika Kiyo. 2021 Jan;67(1):37-41. doi: 10.14989/ActaUrolJap_67_1_37.

DOI:10.14989/ActaUrolJap_67_1_37
PMID:33535296
Abstract

A 69-year-old man presented with gross hematuria. Cystoscopy revealed a large papillary tumor occupying the bladder. Magnetic resonance imaging showed a large bladder tumor more than 8cm in maximum diameter,suspected to be muscle-invasive disease. We performed the 1st transurethral resection of bladder tumor (TURBT) for the main purpose of pathological confirmation. Histopathological findings of the resected specimens showed urothelial carcinoma,low grade pTa. We performed subsequent treatments with TURBT twice,resulting in complete resection. The histopathological findings showed the same results as those of the 1st TURBT conclusively,which was consistent with non-muscle-invasive bladder cancer. He received intravesical instillation of pirarubicin eight times in total and has remained free from recurrence for more than 26 months after the final TURBT.

摘要

相似文献

1
[Complete Transurethral Resection of Large Non-Muscle-Invasive Bladder Cancer Preoperatively Suspected to Be Muscle-Invasive Disease : A Case Report and Literature Review].
Hinyokika Kiyo. 2021 Jan;67(1):37-41. doi: 10.14989/ActaUrolJap_67_1_37.
2
Effect of Intravesical Instillation of Gemcitabine vs Saline Immediately Following Resection of Suspected Low-Grade Non-Muscle-Invasive Bladder Cancer on Tumor Recurrence: SWOG S0337 Randomized Clinical Trial.经尿道膀胱肿瘤切除术联合吉西他滨或生理盐水即刻膀胱灌注预防低级别非肌层浸润性膀胱癌复发的疗效:SWOG S0337 随机临床试验。
JAMA. 2018 May 8;319(18):1880-1888. doi: 10.1001/jama.2018.4657.
3
Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: a randomised controlled trial.电渗滴注丝裂霉素即刻经尿道膀胱肿瘤切除术治疗原发性非肌层浸润性膀胱尿路上皮癌患者:一项随机对照试验。
Lancet Oncol. 2011 Sep;12(9):871-9. doi: 10.1016/S1470-2045(11)70190-5. Epub 2011 Aug 8.
4
[Value of European Organisation for Research and Treatment of Cancer score system for predication of immediate postoperative intravesical instillation of pirarubicin after transurethral resection of non-muscle invasive bladder cancer].[欧洲癌症研究与治疗组织评分系统对非肌层浸润性膀胱癌经尿道切除术后即刻膀胱内灌注吡柔比星预测的价值]
Zhonghua Zhong Liu Za Zhi. 2018 Apr 23;40(4):308-312. doi: 10.3760/cma.j.issn.0253-3766.2018.04.014.
5
[The intravesical recurrence after 3-day consecutive intravesical instillation of pirarubicine hydrochloride (THP) following transurethral resection of bladder tumor (TURBT) for non-muscle-invasive bladder cancer].非肌层浸润性膀胱癌经尿道膀胱肿瘤电切术(TURBT)后连续3天膀胱内灌注盐酸吡柔比星(THP)后的膀胱内复发情况
Nihon Hinyokika Gakkai Zasshi. 2012 Jul;103(4):610-6. doi: 10.5980/jpnjurol.103.610.
6
Prospective randomized controlled trial of postoperative early intravesical chemotherapy with pirarubicin (THP) for solitary non-muscle invasive bladder cancer comparing single and two-time instillation.吡柔比星(THP)单次与两次膀胱灌注用于单发非肌层浸润性膀胱癌术后早期腔内化疗的前瞻性随机对照研究
World J Urol. 2018 Jun;36(6):889-895. doi: 10.1007/s00345-018-2196-8. Epub 2018 Jan 31.
7
Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation across time and place and recommendation for benchmarking.高质量白光经尿道膀胱肿瘤切除术(GQ-WLTURBT)结合经验丰富的外科医生进行完整切除并获得逼尿肌,可降低新非肌肉浸润性膀胱癌的早期复发率:跨时间和地点的验证以及基准建议。
BJU Int. 2012 Jun;109(11):1666-73. doi: 10.1111/j.1464-410X.2011.10571.x. Epub 2011 Nov 1.
8
Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.再次经尿道膀胱肿瘤切除术(re-cTURBT)作为pT1期高级别(HG)疾病复发和进展的风险指标是否有用?一项单中心经验。
Arch Ital Urol Androl. 2017 Dec 31;89(4):272-276. doi: 10.4081/aiua.2017.4.272.
9
Value of an Immediate Intravesical Instillation of Mitomycin C in Patients with Non-muscle-invasive Bladder Cancer: A Prospective Multicentre Randomised Study in 2243 patients.表柔比星联合顺铂膀胱灌注化疗预防膀胱癌术后复发的多中心随机对照研究 表柔比星联合顺铂膀胱灌注化疗预防膀胱癌术后复发的多中心随机对照研究 表柔比星联合顺铂膀胱灌注化疗预防膀胱癌术后复发的多中心随机对照研究 表柔比星联合顺铂膀胱灌注化疗预防膀胱癌术后复发的多中心随机对照研究
Eur Urol. 2018 Feb;73(2):226-232. doi: 10.1016/j.eururo.2017.06.038. Epub 2017 Jul 10.
10
The value of immediate postoperative intravesical epirubicin instillation as an adjunct to standard adjuvant treatment in intermediate and high-risk non-muscle-invasive bladder cancer: A preliminary results of randomized controlled trial.即刻膀胱内表柔比星灌注作为中高危非肌层浸润性膀胱癌标准辅助治疗的辅助手段的价值:一项随机对照试验的初步结果。
Urol Oncol. 2019 Mar;37(3):179.e9-179.e18. doi: 10.1016/j.urolonc.2018.10.019. Epub 2018 Nov 14.